Dexanabinol (HU-211) is a synthetic non-psychotropic cannabinoid and a non-competitive NMDA-receptor antagonist. The beneficial effect of dexanabinol on prevention of degeneration and promotion of regeneration was studied on the crush-injured rat optic nerve model. Sprague-Dawley rats were subjected to a calibrated crush injury of the optic nerve and treated with a single intraperitoneal injection of dexanabinol (7 mg/kg), its vehicle only or were untreated. Transmission electron microscopic analysis of the excised optic nerves was performed after 30 days. In the dexanabinol treated rats, the site of injury was traversed by unmyelinated and thinly myelinated axons, possibly indicative of regenerative growth. No such growth was detectable in the controls. Viable axons were found 0.5 mm distal to the site of injury in 6 of 8 dexanabinol treated rats, but in only 1 of 10 rats in the control groups.
Introduction
The permanent disablement caused by mechanical insult in traumatic brain injury, or the acute initial anoxia in ischemic injury, is caused by the primary insult, by the secondary degeneration that follows the lesion and the failure of the mammalian central nervous system (CNS) to regenerate. Thus, injury to the mammalian optic nerve, for example, leads to axonal degeneration followed by a loss of retinal ganglion cells. Even if the lesion is partial, the degeneration gradually spreads beyond the primary area of damage to fibers that escaped the primary insult. The final result of such injuries may be changed by neuroprotection, i.e., prevention and/or attenuation of secondary degeneration and by promotion of regenerative growth. It is therefore logical to seek a neuroprotective treatment that can reduce or alleviate the secondary degeneration and thusfavorably affect the overall outcome of the injury. A number of candidate compounds for this purpose have been examined, among them dexanabinol (HU-211), a synthetic analog of tetrahydrocannabinol, which lacks psychotropic activity. HU-211 acts as a non-competitive antagonist of the Nmethyl-D D -aspartate (NMDA) receptor, and has both anti-oxidant properties (Eshhar, Striem, & Biegon, 1994; Feigenbaum et al., 1989; Nadler, Mechoulam, & Sokolovsky, 1993a,b) and cytokine-inhibitory effects (Shohami, Gallily, Mechoulam, Bass, & Ben-Hur, 1997) . It exerts neuroprotective activity in various animal models (Bar-Ilan, Neuman, & Solomon, 1995; Bar-Joseph, Berkovitch, Adamchick, & Biegon, 1994; Belayev, BarJosef, Adamchik, & Biegon, 1995a,b; Biegon & BarJoseph, 1995; Shohami, Novikov, & Mechoulam, 1993 . In the present study we directed our attention to the long term (30 days) effect of dexanabinol on injured CNS. Specifically, we examined the morphological manifestations following a moderate crush injury of the rat optic nerve. The morphological examination by transmission electron microscopy enables distinguishing between survived and newly growing axons (Lavie et al., 1990) . The long period of 30 days after the lesion insures that viable axons found distal to the site of injury are not abortive (Richardson, Issa, & Shemie, 1982) thus provide evidences for the beneficial effect of dexanabinol on injured CNS.
Materials and methods

Surgery
All animals were treated according to the ARVO resolution on the treatment of animals in research. Male Sprague-Dawley (SPD) rats, 3-4 months old and weighing 300-400 gr, were anesthetized by intraperitoneal (i.p.) injections of ketamine (50 mg/kg of a 10% solution) and xylazine (0.5 mg/kg of a 2% solution). With the aid of a binocular surgical microscope, lateral canthotomy and limbal peritomy of the conjuctiva were performed. The recti muscles were cut at their scleral insertion and separated from the eyeball. From its origin at the sclera, the optic nerve was exposed by blunt dissection along a length of about 3-3.5 mm. The dura was left intact and care was taken not to injure the optic nerve or the retinal blood supply. A controlled crush injury was then inflicted 1-2 mm from the optic nerve origin at the sclera, with the aid of calibrated crossaction forceps with a force equivalent to 120 gr for 30 s, resulting in a moderate crush lesion (Duvdevani et al., 1990) .
Treatments
All animals were treated according to the ARVO resolution on the treatment of animals in research. A total of 18 rats were subjected to optic nerve crush. Immediately after the crush injury, rats were treated with a single i.p. injection of HU-211 (7 mg/kg (Pharmos Ltd., Rehovot, Israel) in 0.5 ml Migliol (a medium-chain triglyceride) (n ¼ 8)). Control groups of injured rats were either injected with the vehicle only (n ¼ 5) or were untreated (n ¼ 5).
Transmission electron microscopy
Thirty days after the injury, the number of axons that were still viable, were counted in HU-211-treated and control injured nerves, using transmission electron microscopy (TEM). The optic nerves were excised and fixed by immersion in fresh Karnovsky fixative containing 1% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer pH 7.4, containing 2.5% CaCl 2 for about 15 min at room temperature and then overnight at 4°C. Twenty-four hours later the nerves were cut serially with a razor blade into 1 mm thick segments which were stained en bloc with (2%) aqueous uranyl acetate, osmicated, dehydrated in series of ethanols followed by propylene oxide and finally embedded in Polybed (Polysciences Inc., Warrington, PA) and cured at 60°C. Thin cross-sections were taken from a site 1 mm proximal to the site of injury, through the site of injury and 0.5 mm distal to it. If needed, sections were also taken at areas further distally. The sections were placed on formvar-coated, one-slot grids, counter stained and analyzed as a whole for the presence of viable axons, using a Philips 410 TEM. At the distance of 0.5 mm distally from the site of injury, all viable axons were photographed, classified and counted. All observations were done in a masked fashion by an investigator unaware of the treatment. An axonal profile was classified as a healthy myelinated axon if its axoplasm was lucent, its microtubules and neurofilaments were aligned and its myelin sheath was well preserved. It was classified a health thinly myelinated or unmyelinated axon if it had little or no myelin, but lucent cytoplasm containing aligned microtubules, neurofilaments, and occasional vesicles (Murray, 1982) . A fiber with a thick myelin sheath was considered as a surviving axon. Unmyelinated axons, thinly myelinated axons and growth cones were considered as growing axons.
Differences between the groups were analyzed by Fisher Exact Test. A probability value of less than 5% was considered to be statistically significant.
Results
In all 8 of the HU-211-treated optic nerves, surviving axons characterized by a normal-looking thick myelin sheath (Fig. 1a) were seen along the stump proximal to the site of injury, and in 6 of these nerves they could also be detected 0.5 mm distal to the injury site. Only a few surviving axons were detected in 4 of the 10 control animals (we combined the two control groups, since there was no significant difference between them) and only in 1 of these 10 controls few surviving axons were detected 0.5 mm distal to the site of injury. (Fig. 2a) . (Treated animals were significantly different from control: p < 0:005 by Fisher exact test). In 7 of the 8 HU-211-treated rats we also found, at the same distal site, unmyelinated and thinly myelinated axons (Fig. 1b,c) , as well as growth cone profiles (Figs. 1d and 2b ) all arranged in a special compartment--the compartment of viable axons (Lavie et al., 1990) . A few unmyelinated axons could be detected at the corresponding sites in only 1 of the 10 control rats. In all the other control animals, only degenerating and surviving axons (Fig. 3) could be seen. In all, treated and untreated animals, no thinly myelinated or unmyelinated axons could be detected at sites further than 0.5 mm distally from the site of injury. 
Discussion
The results of this study show that HU-211, when injected intraperitoneally in rats immediately after a moderate crush injury of the optic nerve, attenuates axonal degeneration and promotes axonal growth.
In the rat optic nerve model, the crush injury inflicted on the nerve causes irreversible damage to some of the axons, which consequently degenerate, and their cell bodies die. The rest of the fibers may initially suffer marginal damage or no damage at all. They are, however, exposed to injury-induced mediators of toxicity and, in the absence of treatment, will eventually undergo secondary degeneration.
Dexanabinol (HU-211) is a synthetic analog of tetrahydrocannabinol which lacks psychotropic activity. Several in vitro and in vivo pharmacological studies have described HU-211 as a functional neuroprotective agent which probably has multiple mechanisms of action. It is a non-competitive NMDA receptor antagonist that blocks NMDA-induced uptake of Ca 2þ into primary rat forebrain (Nadler, Biegon, Beit-Yannai, Adamchik, & Shohami, 1995) and hippocampal cells in cultures (Kachalsky, 2000) . It also attenuates Ca 2þ accumulation in the rat brain after closed head injury suggesting that it inhibits the influx of Ca 2þ across the NMDA-receptor-linked ion channel . HU-211 also affects or modulates the inflammatory response following brain injury. It helps to prevent the release of tumor necrosis factor (TNF-a) in the brain following closed head injury (Shohami et al., 1997) . Yoles, Belkin, and Schwartz (1996) had shown in the rat optic nerve crush injury model, that HU-211 significantly attenuates the immediate injury-induced decline in energy production. In the same study, the visual evoked potential responses and the compound action potentials of the optic nerves of HU-211-treated animals, measured 2 weeks after the injury, were significantly higher than those of vehicle-treated animals.
In the present study counting viable surviving and growing-axons were done in a series of cross-sections from a site 1 mm proximal to the site of injury, through the site of injury and 0.5 mm distal to it and if needed, at areas further distally. Using this method, we were able to ensure that we can actually detect all viable axons in each section. The neuroprotective effect of HU-211, manifested by the surviving axons in 6 of the 8 HU-211-treated rats 30 days after the injury, was in line with the conclusions of the studies mentioned above. However, in 7 of the 8 HU-211-treated rats we also found profiles of growing axons, which have traversed the site of injury and penetrated, to a limited distance, into the distal stump. These results suggest that HU-211 may also promote axonal growth. The period of time of 30 days after the injury reduces the probability that these axons are abortive (Richardson et al., 1982) . These axons were not found in areas further distally therefore they could not be considered as surviving axons that were demyelinated. Similar results were reported after treatment of crush-injured optic nerves with media conditioned with regenerating fish optic nerve (Lavie et al., 1990; Schwartz et al., 1985) , media conditioned with newborn rabbit optic nerve (Hadani et al., 1984) , or transglutaminase (Eitan et al., 1994) .
The apparent ability of HU-211 to promote axonal growth might be related to the known activity of the NMDA receptor in affecting the form of axonal arborization in several regions of the CNS. Such an effect was shown in hippocampal slice cultures when application of NMDA receptor antagonist induced massive axonal sprouting, (McKinney, L€ u uthi, Bandtlow, & G€ a ahwiler, 1999) . The link between changes in NMDA-receptor activation and changes in the rate of neurite extension might be the ''stop growing'' signal mentioned by Baired, Trenkner, and Mason (1996) who have shown that NMDA receptors are involved in the development and establishment of synaptic circuitry of the tectum, lateral geniculate nucleus, visual cortex and trigeminal nucleus. In cultured cerebellar neurons treated with NMDAreceptor antagonists, the axons extended for longer distances over target cell compared with untreated controls. It is reasonable to assume that HU-211, being an antagonist to the NMDA receptor, may arrest the stop growing signal, thereby promote regeneration.
HU-211 has an effect on the prevention of TNF-a release as was demonstrated in the models of closed head injury (Shohami et al., 1993 (Shohami et al., , 1997 . TNF-a seems to exert a bimodal effect on the CNS, causing axonal degeneration on one hand and possibly promoting axonal growth on the other. The bimodal effect may be related to differences in receptor subtypes, activation of different signal transduction pathways, or the presence of molecules that modify intracellular response elements (Pan et al., 1997) . This might explain why systemic injection of HU-211, which prevents TNF-a release, resulted in similar effect of attenuation of secondary degeneration and promoting axonal growth like the application of TNF-a to the site of injury of the optic nerve (Schwartz et al., 1991) .
Conclusion
Dexanabinol (HU-211), as manifested morphologically in the rat model of crush-injured rat optic nerve, is neuroprotective, since it attenuates axonal degeneration and promotes axonal survival across the site of injury. It also has a possible beneficial effect on regeneration, as demonstrated 30 days post-injury. Further studies are needed in order to understand the mechanisms by which HU-211 attenuates degeneration and apparently stimulates axonal growth. Thus, ways to facilitate regeneration may be found.
